It has been reported that free hemoglobin (Hb) reacts with NO at an extremely high rate (K Hb ϳ10
M؊1 s ؊1 ) and that the red blood cell (RBC) membrane is highly permeable to NO. RBCs, however, react with NO 500 -1000 times slower. This reduction of NO reaction rate by RBCs has been attributed to the extracellular diffusion limitation. To test whether additional limitations are also important, we designed a competition test, which allows the extracellular diffusion limitation to be distinguished from transmembrane or intracellular resistance. This test exploited the competition between free Hb and RBCs for NO generated in a homogenous phase by an NO donor. If the extracellular diffusion resistance is negligible, then the results would follow a kinetic model that assumes homogenous reaction without extracellular diffusion limitation. In this case, the measured effective reaction rate constant, K RBC , would remain invariant of the hematocrit, extracellular-free Hb concentration, and NO donor concentration. Results show that the K RBC approaches a constant only when the hematocrit is greater than 10%, suggesting that at higher hematocrit, the extracellular diffusion resistance is negligible. Under such a condition, the NO consumption by RBCs is still 500 -1000 times slower than that by free Hb. This result suggests that intrinsic RBC factors, such as transmembrane diffusion limitation or intracellular mechanisms, exist to reduce the NO consumption by RBCs.Despite the well documented importance of nitric oxide, the transfer of NO from the producing cell to the target is poorly understood, because the free radical NO can be degraded in a variety of reactions. In particular, NO reacts with deoxy-and oxyhemoglobin (deoxyHb and oxyHb, respectively) 1 at a very high rate (1, 2) to form nitrosyl Hb (HbNO) and met hemoglobin (metHb), respectively. If Hb in the RBC behaved like Hb in dilute solution, the half-life of NO in the blood (which contains about 12-15 mM heme) would be only about 1 s. For such a rapid reaction, it would seem likely that a large portion of NO produced from the endothelium would be scavenged by the blood.Indeed, in vivo and in vitro evidence suggests that free Hb is an effective NO scavenger that can deplete NO. For example, infusion of free Hb solution into experimental animals or human subjects results in hypertension (3, 4), most likely due to the reaction of NO with oxyHb in the circulation (3). Modeling analyses (5-7) also showed that if endothelium-produced NO reacted as rapidly with blood as it does with free Hb, the NO concentrations in vascular smooth muscle would be too low to activate soluble guanylate cyclase, the primary target of NO. Mathematical modeling based on diffusion theory and in vitro measurements of kinetic constants (5-8) have confirmed that Hb could effectively scavenge endothelial produced NO and mitigate its effect. Because 3-10 M free Hb can abolish NOmediated vasodilation in vitro (4, 9), it is unclear how NO can exercise its vasoregulatory function with 12-15 mM Hb c...